# 🔬 CRITICAL EXPERT REVIEW: Bioinformatics & Statistical Analysis

**Date:** 2025-01-21  
**Reviewer Perspective:** Expert Bioinformatics & Statistical Analysis  
**Review Type:** Comprehensive Critical Assessment

---

## 🎯 EXECUTIVE SUMMARY

This pipeline demonstrates **good overall structure** and **reproducibility**, but has **critical statistical and methodological gaps** that limit scientific rigor and publication readiness. This review identifies **high-priority issues** that must be addressed before publication or use in production.

**Overall Assessment:** ⚠️ **NEEDS SIGNIFICANT IMPROVEMENTS**

**Priority Areas:**
1. 🔴 **CRITICAL:** Statistical assumptions validation
2. 🔴 **CRITICAL:** Batch effect analysis
3. 🔴 **CRITICAL:** Confounder control
4. 🟡 **HIGH:** Missing value/zero handling
5. 🟡 **HIGH:** Methodological documentation
6. 🟡 **HIGH:** Functional analysis validation

---

## 🔴 CRITICAL STATISTICAL ISSUES

### 1. **NO VALIDATION OF STATISTICAL ASSUMPTIONS** ⚠️⚠️⚠️

**Problem:**
- t-test is used **without checking normality assumptions**
- No Levene's/Bartlett's test for variance homogeneity
- No visual inspection (Q-Q plots, histograms) of residuals
- Wilcoxon is used as fallback, but rationale for choosing parametric vs non-parametric is not documented

**Impact:**
- **Type I/II error rates may be inflated**
- Invalid p-values and FDR corrections
- Unreliable scientific conclusions

**Evidence:**
```r
# From scripts/step2/01_statistical_comparisons.R
# Line 214-220: t-test performed without assumption checks
t_test_pvalue = tryCatch({
  test_result <- t.test(
    Total_Count[Group == "ALS"],
    Total_Count[Group == "Control"],
    alternative = "two.sided"
  )
  test_result$p.value
}, error = function(e) NA_real_)
```

**Required Fix:**
```r
# Add assumption validation:
# 1. Shapiro-Wilk test for normality (if n < 50)
# 2. Levene's test for variance homogeneity
# 3. Visual diagnostics (Q-Q plots, histograms)
# 4. Document decision tree: parametric vs non-parametric
```

**Recommendation:**
- Create `scripts/utils/statistical_assumptions.R` with:
  - `check_normality()` function
  - `check_variance_homogeneity()` function
  - `diagnostic_plots()` function
  - Automatic test selection based on assumptions

**Priority:** 🔴 **CRITICAL - Must fix before publication**

---

### 2. **NO BATCH EFFECT ANALYSIS** ⚠️⚠️⚠️

**Problem:**
- Metadata template includes `batch` column, but **batch effects are never analyzed**
- No Principal Component Analysis (PCA) to detect batch clustering
- No batch correction methods applied (ComBat, limma removeBatchEffect, etc.)
- Batch effects could confound ALS vs Control comparisons

**Impact:**
- **False positives** if batch correlates with group
- **False negatives** if batch masks true differences
- **Uninterpretable results** if batch effects are present

**Evidence:**
- `sample_metadata_template.tsv` includes `batch` column
- No scripts analyze batch effects
- No batch correction in statistical comparisons

**Required Fix:**
```r
# Add Step 2.0: Batch Effect Analysis
# 1. PCA colored by batch
# 2. ANOVA testing batch effect on principal components
# 3. Visualization of batch clustering
# 4. Batch correction if significant (ComBat, limma, etc.)
```

**Recommendation:**
- Create `scripts/step2/00_batch_effect_analysis.R`
- Add batch correction to `01_statistical_comparisons.R`
- Document batch correction method in pipeline

**Priority:** 🔴 **CRITICAL - Must fix before publication**

---

### 3. **NO CONFOUNDER CONTROL** ⚠️⚠️⚠️

**Problem:**
- Age, sex, and other covariates are **never analyzed or controlled**
- No adjustment for confounders in statistical models
- No reporting of group matching (age, sex distribution)
- No multivariate regression models

**Impact:**
- **Confounded associations** (age/sex differences could explain ALS vs Control)
- **Uninterpretable results** if groups are not balanced
- **Missing important biological insights**

**Evidence:**
- `sample_metadata_template.tsv` includes `age`, `sex`, `diagnosis`
- No scripts use these covariates
- Statistical comparisons ignore covariates

**Required Fix:**
```r
# Add confounder analysis:
# 1. Group comparison table (age, sex distribution)
# 2. Univariate analysis (t-test/chi-square) for confounders
# 3. Multivariate regression (ANCOVA, GLM) with covariates
# 4. Adjustment for confounders in statistical comparisons
```

**Recommendation:**
- Create `scripts/step2/00_confounder_analysis.R`
- Modify `01_statistical_comparisons.R` to include:
  - ANCOVA model: `Count ~ Group + Age + Sex + Batch`
  - GLM with covariates
- Report group balance in summary

**Priority:** 🔴 **CRITICAL - Must fix before publication**

---

### 4. **NO CONFIDENCE INTERVALS FOR EFFECT SIZES** ⚠️⚠️

**Problem:**
- Cohen's d has CIs calculated, but **differences in means have no CIs**
- No bootstrap CIs for fold changes
- No reporting of effect size uncertainty

**Impact:**
- **Cannot assess precision** of estimated differences
- **Cannot make inference** about practical significance
- **Less informative results**

**Evidence:**
```r
# From scripts/step2/03_effect_size_analysis.R
# Lines 86-91: CIs for Cohen's d (approximate)
cohens_d_ci_lower = cohens_d - 1.96 * se_cohens_d,
cohens_d_ci_upper = cohens_d + 1.96 * se_cohens_d
# But no CIs for mean differences or fold changes
```

**Required Fix:**
```r
# Add to comparison_results:
# 1. 95% CI for mean difference (ALS_mean - Control_mean)
# 2. Bootstrap CI for fold change (if distribution is skewed)
# 3. CI for log2FC
```

**Recommendation:**
- Add CIs to `01_statistical_comparisons.R`
- Report CIs in summary tables
- Visualize CIs in volcano plots

**Priority:** 🟡 **HIGH - Important for publication**

---

### 5. **NO POWER ANALYSIS** ⚠️⚠️

**Problem:**
- No calculation of statistical power
- No reporting of minimum detectable effect size
- No sample size justification

**Impact:**
- **Cannot assess if study is underpowered**
- **Cannot interpret negative results** (no difference vs. no power)
- **Less informative for future studies**

**Required Fix:**
```r
# Add power analysis:
# 1. Post-hoc power analysis (what was the power for observed effects?)
# 2. Minimum detectable effect size (MDE) calculation
# 3. Sample size recommendations for future studies
```

**Recommendation:**
- Create `scripts/utils/power_analysis.R`
- Add to Step 2 summary report
- Document in methodology

**Priority:** 🟡 **HIGH - Important for publication**

---

## 🟡 HIGH PRIORITY METHODOLOGICAL ISSUES

### 6. **INCOMPLETE MISSING VALUE/ZERO HANDLING** ⚠️⚠️

**Problem:**
- No explicit documentation of how zeros/missing values are handled
- No analysis of zero-inflation
- No distinction between "true zero" (no mutation) vs "missing" (no data)
- No sensitivity analysis for different zero-handling strategies

**Impact:**
- **Unclear interpretation** of results
- **Potential bias** if zeros are handled incorrectly
- **Limited reproducibility**

**Evidence:**
- `na.rm = TRUE` used throughout, but rationale not documented
- No zero-inflation analysis
- No documentation of zero handling strategy

**Required Fix:**
```r
# Add zero-inflation analysis:
# 1. Count zeros per sample/miRNA
# 2. Test for zero-inflation (Vuong test)
# 3. Document zero-handling strategy
# 4. Sensitivity analysis (exclude zeros vs. include as zeros)
```

**Recommendation:**
- Document zero-handling in `docs/METHODOLOGY.md`
- Add zero-inflation analysis to Step 1.5
- Create sensitivity analysis script

**Priority:** 🟡 **HIGH - Important for rigor**

---

### 7. **SIMPLIFIED FUNCTIONAL ANALYSIS (NOT BIOLOGICALLY VALID)** ⚠️⚠️

**Problem:**
- Target prediction uses **placeholders**, not real databases
- No integration with TargetScan, miRDB, or multiMiR
- ALS-relevant genes are **hardcoded**, not validated
- No validation of target predictions

**Impact:**
- **Results are not biologically meaningful**
- **Cannot be used for real biological interpretation**
- **Misleading conclusions**

**Evidence:**
```r
# From scripts/step3/01_functional_target_analysis.R
# Lines 118-119: Placeholder targets
canonical_targets = paste0("TARGET_", miRNA_name, "_CANONICAL"),
oxidized_targets = paste0("TARGET_", miRNA_name, "_OXIDIZED"),
```

**Required Fix:**
```r
# Integrate with real databases:
# 1. multiMiR package (TargetScan, miRDB, miRWalk, etc.)
# 2. targetscan.Hs.eg.db for human targets
# 3. Validate ALS gene list from databases (DisGeNET, etc.)
# 4. Document database versions and methods
```

**Recommendation:**
- Integrate `multiMiR` package
- Create `scripts/utils/target_prediction.R` with real database queries
- Update Step 3 to use real target predictions
- Document database versions and methods

**Priority:** 🟡 **HIGH - Critical for biological validity**

---

### 8. **NO CROSS-VALIDATION FOR BIOMARKER ANALYSIS** ⚠️⚠️

**Problem:**
- ROC curves are calculated on **full dataset** (no train/test split)
- No cross-validation or bootstrap for AUC estimation
- **Overfitting risk** for biomarker signatures
- No independent validation dataset

**Impact:**
- **Overly optimistic AUC estimates**
- **Biomarkers may not generalize**
- **Unreliable diagnostic performance**

**Evidence:**
```r
# From scripts/step4/01_biomarker_roc_analysis.R
# Lines 134-279: ROC calculated on full dataset
for (i in 1:min(nrow(significant_gt), 30)) {
  # ... ROC calculation without train/test split
}
```

**Required Fix:**
```r
# Add cross-validation:
# 1. k-fold CV (k=5 or k=10) for AUC estimation
# 2. Bootstrap confidence intervals for AUC
# 3. Independent test set if available
# 4. Report mean CV AUC ± SD
```

**Recommendation:**
- Add k-fold CV to `scripts/step4/01_biomarker_roc_analysis.R`
- Report CV AUC in addition to full-data AUC
- Document CV methodology

**Priority:** 🟡 **HIGH - Critical for biomarker validity**

---

### 9. **NO REPLICABILITY ANALYSIS** ⚠️

**Problem:**
- No analysis of technical replicates (if available)
- No analysis of biological replicates
- No assessment of reproducibility across batches
- No reporting of replicate consistency

**Impact:**
- **Cannot assess data quality**
- **Cannot identify technical artifacts**
- **Limited confidence in results**

**Required Fix:**
```r
# Add replicability analysis:
# 1. Correlation between technical replicates
# 2. Coefficient of variation (CV) for replicates
# 3. Intra-class correlation coefficient (ICC)
# 4. Visualization of replicate consistency
```

**Recommendation:**
- Add to Step 1.5 if replicate data is available
- Document in methodology

**Priority:** 🟡 **MEDIUM - Important for data quality**

---

### 10. **NO NORMALIZATION DOCUMENTATION/VALIDATION** ⚠️

**Problem:**
- RPM calculation is done, but **normalization method is not documented**
- No validation that normalization is appropriate
- No comparison of different normalization methods
- No assessment of normalization effectiveness

**Impact:**
- **Unclear methodology**
- **Potential bias** if normalization is inappropriate
- **Limited reproducibility**

**Evidence:**
```r
# From scripts/step6/01_expression_oxidation_correlation.R
# Lines 127-168: RPM calculation without documentation
estimated_rpm = estimated_total_reads / n_samples,  # Rough RPM estimate
```

**Required Fix:**
```r
# Document and validate normalization:
# 1. Document RPM calculation method
# 2. Compare RPM vs other methods (CPM, TPM, quantile normalization)
# 3. Visualize normalization effectiveness (PCA, boxplots)
# 4. Choose method based on data characteristics
```

**Recommendation:**
- Document normalization in `docs/METHODOLOGY.md`
- Add normalization validation script
- Compare multiple normalization methods

**Priority:** 🟡 **MEDIUM - Important for methodology**

---

## 📚 DOCUMENTATION GAPS

### 11. **NO COMPREHENSIVE METHODOLOGY DOCUMENT** ⚠️⚠️

**Problem:**
- No detailed methodology document
- No justification of statistical choices
- No documentation of assumptions and limitations
- No reporting standards (STROBE, CONSORT, etc.)

**Impact:**
- **Difficult to reproduce**
- **Difficult to evaluate rigor**
- **Not publication-ready**

**Required Fix:**
- Create `docs/METHODOLOGY.md` with:
  - Statistical methods justification
  - Assumptions and their validation
  - Limitations and caveats
  - Reporting standards compliance

**Priority:** 🟡 **HIGH - Critical for publication**

---

### 12. **NO INTERPRETATION GUIDE** ⚠️

**Problem:**
- No guide for interpreting results
- No explanation of what different statistics mean
- No guidance on how to use results for decision-making
- No troubleshooting guide for common issues

**Impact:**
- **Users may misinterpret results**
- **Limited usability**
- **Potential misuse**

**Required Fix:**
- Create `docs/INTERPRETATION_GUIDE.md` with:
  - How to interpret p-values, FDR, effect sizes
  - How to read volcano plots, ROC curves
  - What to look for in each step
  - Common pitfalls and how to avoid them

**Priority:** 🟡 **MEDIUM - Important for usability**

---

### 13. **NO THRESHOLD JUSTIFICATION DOCUMENT** ⚠️

**Problem:**
- Thresholds are set but **not justified scientifically**
- No literature review supporting thresholds
- No sensitivity analysis for different thresholds
- No documentation of threshold robustness

**Impact:**
- **Arbitrary thresholds** may not be appropriate
- **Unclear scientific rationale**
- **Limited reproducibility**

**Evidence:**
- `docs/UMBRALES_BASADOS_LITERATURA.md` exists but may not be comprehensive
- Thresholds in `config.yaml` not fully justified

**Required Fix:**
- Expand `docs/UMBRALES_BASADOS_LITERATURA.md` with:
  - Literature citations for each threshold
  - Sensitivity analysis results
  - Recommendations for different datasets

**Priority:** 🟡 **MEDIUM - Important for scientific rigor**

---

## 🧹 ORGANIZATIONAL ISSUES

### 14. **TOO MANY TEMPORARY MARKDOWN FILES** ⚠️

**Problem:**
- **86+ Markdown files** in root directory (many temporary)
- Makes navigation difficult
- Suggests incomplete documentation management
- Clutters repository

**Impact:**
- **Difficult to find relevant documentation**
- **Unprofessional appearance**
- **Maintenance burden**

**Required Fix:**
- Archive or delete temporary files:
  - Move historical notes to `docs/archive/`
  - Delete truly temporary files
  - Keep only essential documentation

**Priority:** 🟢 **LOW - Cleanup task**

---

## ✅ STRENGTHS TO MAINTAIN

1. ✅ **Good reproducibility** (Snakemake, environment.yml, software versions)
2. ✅ **Comprehensive pipeline structure** (multiple analysis steps)
3. ✅ **Effect size analysis** (Cohen's d with CIs)
4. ✅ **FDR correction** (Benjamini-Hochberg)
5. ✅ **Configurable thresholds** (centralized in config.yaml)
6. ✅ **Consistent visual theme** (theme_professional)
7. ✅ **Good logging** (structured, timestamped)
8. ✅ **Output validation** (file existence, data quality checks)

---

## 📋 PRIORITIZED ACTION PLAN

### **PHASE 1: CRITICAL STATISTICAL FIXES** (Must fix before publication)

1. **Add statistical assumptions validation** (1-2 days)
   - Create `scripts/utils/statistical_assumptions.R`
   - Add assumption checks to Step 2
   - Document test selection rationale

2. **Add batch effect analysis** (2-3 days)
   - Create `scripts/step2/00_batch_effect_analysis.R`
   - Add batch correction to statistical comparisons
   - Document batch correction method

3. **Add confounder control** (2-3 days)
   - Create `scripts/step2/00_confounder_analysis.R`
   - Add ANCOVA/GLM models with covariates
   - Report group balance

### **PHASE 2: HIGH PRIORITY METHODOLOGICAL IMPROVEMENTS** (Important for publication)

4. **Add confidence intervals for all effect estimates** (1 day)
   - Add CIs to mean differences
   - Add bootstrap CIs for fold changes
   - Visualize CIs in plots

5. **Add power analysis** (1 day)
   - Create `scripts/utils/power_analysis.R`
   - Add to Step 2 summary
   - Document in methodology

6. **Fix functional analysis** (3-5 days)
   - Integrate multiMiR package
   - Replace placeholder targets with real database queries
   - Validate ALS gene list

7. **Add cross-validation for biomarkers** (2-3 days)
   - Add k-fold CV to Step 4
   - Report CV AUC
   - Document methodology

8. **Document missing value/zero handling** (1 day)
   - Add zero-inflation analysis
   - Document strategy
   - Create sensitivity analysis

### **PHASE 3: DOCUMENTATION & CLEANUP** (Important for usability)

9. **Create comprehensive methodology document** (2-3 days)
   - Write `docs/METHODOLOGY.md`
   - Justify statistical choices
   - Document assumptions and limitations

10. **Create interpretation guide** (1-2 days)
    - Write `docs/INTERPRETATION_GUIDE.md`
    - Explain statistics and plots
    - Add troubleshooting

11. **Clean up temporary files** (1 day)
    - Archive or delete temporary Markdown files
    - Organize documentation

---

## 📊 ESTIMATED EFFORT

- **Phase 1 (Critical):** 5-8 days
- **Phase 2 (High Priority):** 9-13 days
- **Phase 3 (Documentation):** 4-6 days
- **Total:** 18-27 days of focused work

---

## 🎯 RECOMMENDATIONS FOR IMMEDIATE ACTION

1. **Start with Phase 1** (critical statistical fixes)
2. **Create methodology document** (parallel with Phase 1)
3. **Fix functional analysis** (critical for biological validity)
4. **Add cross-validation** (critical for biomarker validity)

---

**Generated:** 2025-01-21  
**Reviewer:** AI Expert Bioinformatics & Statistical Analysis  
**Next Review:** After Phase 1 implementation

